⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Drug Eruption After Subcutaneous Ofatumumab Exposure in Two Patients with Relapsing Multiple Sclerosis (P2-6.009)

Sarah Bou Reslan Raissa Aoun Nada Abou-Fayssal

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

To report and illustrate adverse skin reactions related to ofatumumab use.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Reslan et al. (2024) studied this question.

synapsesocial.com/papers/68e6fcb5b6db643587676ecd https://doi.org/10.1212/wnl.0000000000205457

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Case Report: Severe psoriasis skin lesions following ofatumumab treatment for multiple sclerosis2025 · 2 citations
2Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system2024 · 5 citations
3Effects of Ofatumumab Treatment on Immune Cells Landscape in Patients With Relapsing-remitting Multiple Sclerosis (P7-6.014)2024
4Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosisRCT · 2018 · 219 citations
5Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosisRCT · 2014 · 278 citations